Almotriptan 12.5 mg in menstrually related migraine: A randomized, double-blind, placebo-controlled study

Background: Menstrually related migraine (MRM) affects more than half of female migraineurs. Because such migraines are often predictable, they provide a suitable target for treatment in the mild pain phase. The present study was designed to provide prospective data on the efficacy of almotriptan fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Allais, Gianni, Bussone, Gennaro, D’Andrea, Giovanni, Moschiano, Franca, d’Onofrio, Florindo, Valguarnera, Fabio, Manzoni, Gian Camillo, Grazzi, Licia, Allais, Rita, Benedetto, Chiara, Acuto, Giancarlo
Formato: Texto
Lenguaje:English
Publicado: SAGE Publications 2011
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057443/
https://www.ncbi.nlm.nih.gov/pubmed/20660540
http://dx.doi.org/10.1177/0333102410378048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057443/
https://www.ncbi.nlm.nih.gov/pubmed/20660540
http://dx.doi.org/10.1177/0333102410378048

Ejemplares similares